• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

HeartFlow

HeartFlow stakes $90m step toward $150m Series E

December 5, 2017 By Brad Perriello

HeartFlow took a $90 million step toward the $150 million it hopes to raise in a Series E round for the cardiac imaging technology it’s marketing. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across […]

Filed Under: Cardiovascular, Funding Roundup, Imaging, Wall Street Beat Tagged With: HeartFlow

Report: HeartFlow’s estimated $150m Series E would make it medtech’s latest unicorn

December 1, 2017 By Brad Perriello

A reported Series E round for HeartFlow, estimated at $150 million, would value the company at more than $1 billion, vaulting it into unicorn territory. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across […]

Filed Under: Cardiovascular, Funding Roundup, Imaging, Wall Street Beat Tagged With: HeartFlow

HeartFlow wins CMS new tech payment classification for FFRct analysis

November 6, 2017 By Fink Densford

HeartFlow said today that the Centers for Medicare & Medicaid Services finalized a new technology ambulatory payment classification for its HeartFlow FFRct analysis designed to help diagnose suspected coronary artery disease. Under the newly finalized payment decision, Medicare-enrolled hospitals will be eligible for reimbursements of $1,450.50 for each technical component of the FFRct analysis. The new […]

Filed Under: Blood Management, Business/Financial News, Diagnostics Tagged With: HeartFlow

Corindus Vascular Robotics to test-drive HeartFlow’s 3D cardiac imaging tech

October 24, 2017 By Christopher Calnan

Corindus Vascular Robotics (OTC:CVRS), a Massachusetts-based surgical robotics company, plans to utilize technology that creates 3D images of arteries for evaluating patients. Company officials said they’d employ California-based HeartFlow’s FFRct Analysis in a case series of robotic-assisted percutaneous coronary interventions to evaluate the technology’s role in clinical decision support. The testing will be done at hospitals […]

Filed Under: Cardiovascular, Imaging, Robotics Tagged With: Corindus Vascular Robotics, HeartFlow

HeartFlow wins positive policy decisions from 3 BCBS providers

August 31, 2017 By Fink Densford

HeartFlow said today it won positive medical policies for its HeartFlow FFRct fractional flow reserve analysis system from 3 separate Blue Cross Blue Shield providers. The Redwood City, Calif.-based company said that Anthem Blue Cross Blue Shield, Blue Shield of California and Blue Cross and Blue Shield of Alabama issued positive medical policies supporting the […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: HeartFlow

Philips, HeartFlow ink co-selling, co-dev deals

August 28, 2017 By Fink Densford

Royal Philips (NYSE:PHG) said today it inked a collaborative deal with HeartFlow to promote HeartFlow’s FFRct Analysis system along with Philips’ catheters for assessing coronary arteries in patients with suspected coronary artery disease. HeartFlow’s FFRct fractional flow reserve software is designed to aid in the diagnosis and treatment of patients with suspected coronary artery disease, providing insight […]

Filed Under: Business/Financial News, Cardiovascular, Imaging, Vascular Tagged With: HeartFlow, Philips

HeartFlow touts 4 positive BCBS policy decisions for its FFRct tech

August 8, 2017 By Fink Densford

HeartFlow said today it won positive medical policy decisions from 4 different Blue Cross Blue Shield groups across the US for its HeartFlow FFRct fractional flow reserve technology. The Redwood City, Calif.-based company said that Horizon BCBS of New Jersey, BCBS of Arizona, BCBS of Idaho and BCBS of Kansas City issued determinations supporting the use […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular Tagged With: HeartFlow

GE Healthcare inks deal to integrate HeartFlow FFRct into CT scanners

July 6, 2017 By Fink Densford

GE Healthcare (NYSE:GE) said today it inked a collaborative deal with HeartFlow to integrate its FFRct fractional flow technology into GE’s computed tomography scanners. HeartFlow’s FFRct software is designed to aid in the diagnosis and treatment of patients with suspected coronary artery disease, providing insight into the extent of the CAD and the impact it is […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Imaging, Software / IT Tagged With: GE Healthcare, HeartFlow

HeartFlow wins AMA CPT codes for FFRct cardiac tech

July 5, 2017 By Fink Densford

HeartFlow said today it won a new set of category III Current Procedural Terminology codes from the American medical Association for its FFRct fractional flow reserve technology. The newly won CPT code application was submitted by the American College of Cardiology, the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Angiography and Interventions, […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: HeartFlow

HeartFlow wins BCBS positive review

June 13, 2017 By Fink Densford

UPDATE: Corrected to reflect that HeartFlow won a positive review, not reimbursement, and the source was a press release, not an SEC filing. HeartFlow said today it won a positive healthcare evidence review from Blue Cross Blue Shield’s Evidence Street for its HeartFlow FFRct technology. In the review, BCBS’s Evidence Street determined that the FFRct technology […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: HeartFlow

DJO Global names new surgical prez | Personnel Moves – June 1, 2017

June 1, 2017 By Sarah Faulkner

DJO Global said this week that it hired Jeffery McCaully as global president of its surgical business, effectively immediately. McCaulley succeeded Brady Shirley, who was named DJO’s president & CEO in November last year. McCaulley previously served as president & CEO of Smiths Medical, as well as president of Zimmer Biomet‘s (NYSE:ZBH) global reconstructive unit, where […]

Filed Under: Wall Street Beat Tagged With: Companion Medical, CytoSorbents Corp., Daxor Corp., DJO Global, EnXray, GE Healthcare, Gecko Biomedical, HeartFlow, Insulet, integer, Medtronic, Novartis, Nuvasive, Smiths Medical, Zimmer Biomet

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS